How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials
Media — REMAP-CAP Trial
Understanding Adaptive Platform Trials & REMAP-CAP - SingHealth
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial - The Lancet Oncology
The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP - REBEL EM - Emergency Medicine Blog
REMAP-CAP
REMAP-CAP - Combacte
Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial - The Lancet Infectious Diseases
REMAP-CAP – The Bottom Line
ProtecT and CAP trial recruitment phases and endpoint assessment... | Download Scientific Diagram
Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions (Patrick Lawler, MD, MPH) - Rethinking Clinical Trials
Celebrating REMAP – CAPs success on International Clinical Trials Day – ACTA – Australian Clinical Trials Alliance
REMAP-CAP Trial
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial - The Lancet Oncology
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT–FFR Trial | Circulation: Cardiovascular Interventions
High dose vitamin C 'ineffective' in treating Covid-19, but statin beneficial | NIHR
CAP - Trial Practice, Second Edition (9780769855332). Authors: Michael Martin, Paul Radvany, Lawrence Dubin, Thomas F. Guernsey. Carolina Academic Press
March: Prostate cap trial | News and features | University of Bristol
Changing Perceptions of Phase 1 Cancer Clinical Trials - NCI
Presentations — ATTACC-CAP
NIH ACTIV Therapeutics Clinical Trials: Host Tissue-Directed Therapeutics
HOPE-3 trial of DMD therapy CAP-1002 to continue as planned
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
